Skip to content
NYSE: IGC | Borse Berlin: IGS1.BE | Frankfurt: IGS1
IGC

IGC

India Globalization Capital Inc.

  • Home
  • Life Sciences
  • Infrastructure Business
  • Investors
    • Events and Presentations
    • Press Releases
    • SEC Filings
    • Leadership
    • XBRL Files
    • Governance

IGC Announces Issuance of Second Patent for the Treatment of Alzheimer’s Using THC

September 21, 2022 by Alejandro

IGC Announces Issuance Of 2nd Patent ForTreatment Of Alzheimer’s Using THC IGC 507 US #1446276

Posted in News and Filings, Press Releases

Post navigation

← IGC Announces Results of its 2022 Annual Stockholders Meeting
IGC Reports Financial Results for the Quarter Ended September 30, 2022 →

Site Map

  • Home
  • Life Sciences
  • Infrastructure Business
  • Investors
    • Events and Presentations
    • Press Releases
    • SEC Filings
    • Leadership
    • XBRL Files
    • Governance

Contact

IGC
Potomac, MD, United States

info@igcinc.us
301-983-0998